Δ 9-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain;Keine synergistische wirkung der kombination von Δ 9-tetrahydrocannabinol und piritramid bei postoperativen schmerzen

Anaesthesist

Volumn 55, Issue 4, 2006, Pages 391-400

  Seeling, W ^a   Kneer, L ^a   Buchele B ^a   Gschwend, J ^a   Maier, L ^a   Nett, C ^a   Simmet, T ^a   Steffen, P ^a   Schneider, M ^a   Rockemann, M ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Controlled randomized study; Dronabinol; Interaction; Piritramide; Postoperative pain

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN II ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRONE; DIURETIC AGENT; DRONABINOL; FENTANYL; HEPARIN; LITHIUM; MU OPIATE RECEPTOR AGONIST; ORAL ANTIDIABETIC AGENT; PARACETAMOL; PIRITRAMIDE; PROPOFOL; PROTON PUMP INHIBITOR; ROCURONIUM; STATINE DERIVATIVE;

ADULT; ANTINOCICEPTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; DRUG USE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; RADICAL RETROPUBIC PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; AROUSAL; BODY TEMPERATURE; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; HEMODYNAMICS; HUMANS; LYMPH NODE EXCISION; MALE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PIRINITRAMIDE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECEPTORS, OPIOID, MU; RESPIRATORY MECHANICS; TETRAHYDROCANNABINOL;

EID: 33646235388     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-005-0963-6     Document Type: Article

References (30)

1. 1 and other cannabinoids with emphasis on man. Pharmacol Rev 38:21-43
2. Ashton CH (1999) Adverse effects of cannabis and cannabinoids. Br J Anaesth 83:637-649
3. Buggy DJ, Toogood L, Marie S, Sharpe P, Lambert DG, Rowbotham DJ (2003) Lack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain. Pain 106:169-172
4. Campbell FA, Tramèr MR, Carroll D, Reynolds DJM, Moore RA, McQuay HJ (2001) Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 323:1-6
5. Cichewicz DL (2004) Synergistic interactions between cannabinoid and opioid analgesics. Life Sci 74:1317-1324
6. 9-tetrahydrocannabinol and opioids after oral administration. J Pharmacol Exp Ther 304:1010-1015
7. 9-tetrahydrocannabinol: dose response analysis and receptor identification. J Pharmacol Exp Ther 289:859-867
8. Elphick MR, Egertová M (2001) The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 356:381-408
9. Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signalling. Physiol Rev 83:1017-1066
10. Freye E (2002) Opioide in der Medizin. Wirkung und Einsatzgebiete zentraler Analgetika, 5. Aufl. Springer, Berlin Heidelberg New York Tokyo
11. Fuentes JA, Ruiz-Gayo M, Manzanares J, Vela G, Reche I, Corchero J (1999) Cannabinoids as potential new analgesics. Life Sci 65:675-685
12. 9-tetrahydrocannabinol with oxymorphone or pentobarbital: effects of ventilatory control and cardiovascular dynamics. Anesthesiology 42:674-684
13. Lemberger L, Weiss JL, Watanabe AM, Galanter IM, Wyatt RJ, Cardon PV (1972) Delta-9-tetrahydrocannabinol. Temporal correlation of the psychologic effects and blood levels after various routes of administration. N Engl J Med 286:685-688
14. Manzanares J, Corchero J, Romero J, Fernández-Ruiz JJ, Ramos JA, Fuentes JA (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20:287-294
15. Meng ID, Manning BH, Martin WJ, Fields HL (1998) An analgesia circuit activated by cannabinoids. Nature 395:381-383
16. Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK (1980) Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28:409-416
17. 9-tetrahydrocannabinol. Clin Pharmacol Ther 14:48-55
18. 2 receptors. Pharmacol Ther 74:129-180
19. Pertwee RG (2001) Cannabinoid receptors and pain. Prog Neurobiol 63:569-611
20. Rice ASC (2001) Cannabinoids and pain. Curr Opin Invest Drugs 2:399-414
21. Richardson JD (2000) Cannabinoids modulate pain by multiple mechanisms of action. J Pain 1:2-14
22. Sachs L (1974) Angewandte Statistik. Planung und Auswertung, Methoden und Modelle. Springer, Berlin Heidelberg New York Tokyo
23. Salio C, Fischer J, Franzoni MF, MacKie K, Kaneko T, Conrath M (2001) CB1-cannabinoid and μ-opioid colocalization on postsynaptic target in the rat dorsal horn. Neuroreport 12:3689-3692
24. Shapira M, Gafni M, Sarne Y (1998) Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells. Brain Res 806:26-35
25. Sutin KM, Nahas GG (1999) Physiological and pharmacological interactions of marihuana (THC) with drugs and anesthetics. In: Nahas GG, Sutin KM, Harvey DJ, Agurell S (eds) Marihuana and medicine. Humana Press, Totowa, NJ, pp 253-271
26. Walsh PC (2002) Anatomical radical retropubic prostatectomy. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell's textbook of urology, 8th edn. Saunders, Philadelphia, pp 3107-3129
27. Welch SP, Eads M (1999) Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Res 848:183-190
28. Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678-682
29. Yaksh TL, Al-Rodhan NRF, Jensen TS (1988) Sites of action of opiates in production of analgesia. Prog Brain Res 77:371-394
30. 9-tetrahydrocannabinol in plasma using solid phase extraction and high performance liquid chromatography with electrochemical detection. J Chromatogr 456:83-91